Life Science Partner shares an inside conversation of their recruitment partnership with advanced biologics CDMO, Wheeler Bio.
In the fall of 2022, Jesse McCool, PhD, Founder and CEO and the Board of Directors of Wheeler Bio retained Life Science Partner to recruit their new President and Chief Operating Officer. In partnership with Dr. McCool, Life Science Partner identified, qualified, and recruited Roger Lias, PhD, an industry veteran who was most recently Chief Operating Officer of Vibalogics.
Tom Callaway, MD, Founder of Life Science Partner, sat down with McCool and Lias to discuss Wheeler’s advancements in the Contract Development and Manufacturing Operation (CDMO) market and converse on the two sides of the candidate/client recruitment process.
Wheeler Bio continues their close relationship with Life Science Partner, having additionally recruited their Chief Development Officer, Brian Berquist, PhD, to accelerate their platform and emerge as a technological leader within the CDMO space.
https://lifesciencepartner.com/wp-content/uploads/2024/02/Life-Science-Partner-340-300x138.png00Winnona Partnershttps://lifesciencepartner.com/wp-content/uploads/2024/02/Life-Science-Partner-340-300x138.pngWinnona Partners2022-12-06 14:52:002024-08-07 15:52:06Behind the Scenes Discussion for Building Transformational Leadership with Life Science Partner Founder and Wheeler Bio CEO and COO.
Life Science Partner announces the recruitment of Mark Bogart to serve as Senior Vice President, US Healthcare for B-Secur, a global leader in accelerating the quality of EKG signals to create highly accurate analytics for digital heart health.
Life Science Partner served as a strategic consulting and executive search partner of B-Secur to support their U.S. launch of their signature SaaS technology, HeartKey 2.0®.
This cloud-based solution will accelerate the convergence of medical and consumer health devices by offering a proprietary conditioning, FDA-cleared software to improve health algorithms and wellness insights. B-Secur’s innovative biosensing algorithms refine and enhance signal clarity on micro processing chips (implantable or wearable), for consumer technology partner servers providing novel insights. Their technology also serves as an adjunctive tool for accelerating the adoption of medical device company’s proprietary and patient-centric solutions.
With B-Secur’s technology in high demand to improve signal quality, Bogart will secure and expand relationships with US-based medical device and digital health providers. Additionally, Bogart will build and lead the team to grow the US commercialization opportunities with leading cardiac device companies seeking to bring their EKG monitoring solutions to ambulatory and at-home patients.
“With his subject-matter expertise in digital healthcare and remote patient monitoring combined with his exceptional career as a sales leader, Bogart is well-suited to accelerate B-Secur’s growth and establishment within the US market.”
Tom Callaway, MD, Founder of Life Science Partner
Bogart joins B-Secur after serving as Senior Vice President, US Healthcare for AliveCor, a medical device company that produces ECG hardware and software for mobile devices. Bogart led the healthcare division’s go-to-market strategy spear heading critical partnerships and novel acquisitions during his tenure. Earlier in his career, Bogart served in revenue-generating business development leadership roles at companies such as G Medical Innovations, Viterion Corporation, LifeWatch, ZOLL Medical and Boston Scientific.
Bogart holds a Bachelor of Arts degree in Economics and Political Science from Lake Forest College.
About Life Science Partner
Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.
Life Science Partner is pleased to announce the recruitment of Doug Kelly, MD, MBA as Deputy Director for Science to the Food and Drug Administration’s Center for Devices and Radiological Health (FDA, CDRH).
FDA, CDRH is responsible for protecting and promoting public health by assuring that patients and providers have timely and continued access to safe, effective, and high-quality medical devices and safe radiation-emitting products.
They provide the community with accessible science-based information about the products they oversee and facilitate medical device innovation by advancing regulatory science.
The CDRH also provides industry with predictable, consistent, and transparent regulatory pathways to assure consumer confidence in the devices marketed in the United States.
With the tremendous advancements in technology and a new age for telemedicine and remote patient monitoring, the CDRH is also focusing on advancing their field of digital health. Housed within the CDRH is the Office of Strategic Partnerships and Technological Innovation.
This unit provides leadership for all scientific collaborative and emerging technology, including the new division of Digital Health, which focuses on providing leadership and oversight in the development, review, and implementation of new software services that are aimed at healthcare.
Career Highlights and Contributions
Doug Kelly is a leader in the field of innovative medical technologies. After earning his medical degree from Albert Einstein College of Medicine and his MBA from Stanford University, Kelly was one of the founding members of Ligand Pharmaceuticals, where he served as the Manager of Business Development and helped recruit their Scientific Advisory Board and manage relationships with corporate partners.
In 1996, he helped create a new venture fund, Alloy Ventures, and identified new opportunities for investments in seed- and later-stage medical device, drug discovery, biotechnology and healthcare IT companies.
Dr. Kelly will play a critical, external-facing role for the CDRH and the Office of Strategic Partnerships and Technological Innovation by collaborating with leaders in industry, academia, and healthcare innovation, leveraging his wealth of experience in the medical device investment community.
About Life Science Partner
Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.
Life Science Partner recruits Suso Platero, PhD, to become Division Director of Molecular Genetics & Pathology at the FDA’s Office of Health Technology 7.
Former Oracle SVP, Troy Tazbaz will lead the effort to advance AI and ML for healthcare and help orchestrate a new regulatory environment for digital healthcare. Life Science Partner announces the recruitment of the FDA’s new Division Director for Digital Health and Director for the Digital Health Center of Excellence to prepare the agency to partner with…
Life Science Partner has partnered with the FDA to recruit leaders that can create innovative pathways for early-stage companies to be better prepared for the regulatory review and clearance process. In close collaboration with Jeff Shuren, MD, JD, Head of the Center for Devices and Radiological Health (CDRH) for the FDA, Life Science Partner recruited Doug…
https://i0.wp.com/lifesciencepartner.com/wp-content/uploads/2024/02/doug-kelly.png?fit=324%2C324&ssl=1324324Tom Callawayhttps://lifesciencepartner.com/wp-content/uploads/2024/02/Life-Science-Partner-340-300x138.pngTom Callaway2020-07-21 19:47:002024-11-04 10:16:02Doug Kelly, MD, MBA Joins FDA’s Center for Devices & Radiological Health as Deputy Director for Science
